TargetMol

PD 131628

Product Code:
 
TAR-T33899
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T33899-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33899-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33899-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
PD 131628 is a novel fluoroquinolone that is a bioactive form of PD 131112 or CI-990 for use against anaerobic bacteria.
CAS:
127967-03-7
Formula:
C16H17FN4O3
Molecular Weight:
332.335
Purity:
0.98
SMILES:
N[C@H]1CCN(C1)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1

References

Sewell DL, Barry AL, Allen SD, Fuchs PC, Murray PR, Tenover FC. Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116)). J Antimicrob Chemother. 1996 Jan;37(1):139-43. PubMed PMID: 8647755. Wexler HM, Molitoris E, Reeves D, Finegold SM. In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria. J Antimicrob Chemother. 1994 Oct;34(4):579-84. PubMed PMID: 7868409. Barry AL, Fuchs PC, Citron DM, Allen SD, Wexler HM. Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin. J Antimicrob Chemother. 1993 Jun;31(6):893-900. PubMed PMID: 8395494. Qadri SM, Ueno Y. Susceptibility of Brucella melitensis to the new fluoroquinolone PD 131628: comparison with other drugs. Chemotherapy. 1993 Mar-Apr;39(2):128-31. PubMed PMID: 8384544.